Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genera, formerly known as Veterina, is a leading Croatian pharmaceutical company specializing in animal health. Founded in 1901 and formerly a division of Pliva, the company became independent as Veterina d.d. in 2001 before rebranding to Genera in 2009. The company is a major producer of veterinary vaccines, particularly for poultry and livestock, and operates a state-of-the-art manufacturing facility in Kalinovica, Croatia. In 2015, Genera was acquired by Dechra Pharmaceuticals, a global leader in veterinary medicine, and now serves as a key biologicals manufacturing site for the group. Its portfolio includes well-known vaccine brands such as Gumbokal and Pestikal, serving markets across Europe and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veterina.